Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 16, 2010Journal of Nuclear CardiologyOpen Access

Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with heart failure, coronary artery disease, or those planned to receive implantable…

Design

Review

Authors

NTNagara TamakiKYKeiichiro Yoshinaga

Discussion

Loading...

Member takes

Overview

May support SPECT molecular imaging for HF and CAD risk stratification; leaves open prospective validation trials.

Structured PICO

P
Population
Patients with heart failure, coronary artery disease, or those planned to receive implantable cardioverter-defibrillator treatment
I
Intervention
Molecular imaging using 123I-labeled meta-iodobenzylguanidine (MIBG) and 123I-beta-methyl-iodophenylpentadecanoic acid (BMIPP) with single-photon computed tomography (SPECT)

123I-labeled MIBG and BMIPP provide widely available SPECT-based alternatives to PET for molecular imaging in heart failure and ischemic heart disease.

Cite This Study

Tamaki et al. (2010) studied this question.

synapsesocial.com/papers/69f14b372811130d0cde20b5https://doi.org/10.1007/s12350-010-9305-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy1999 · 68 citations
  2. 2N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.1994 · 236 citations